Benzinga's Top Initiations

Analysts at William Blair initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ: INFI ) with a “market perform” rating. The target price for Infinity Pharmaceuticals is set to $21. Infinity's shares closed at $19.20 yesterday. Credit Suisse initiated coverage on shares of Covance (NYSE: CVD ) with an